Which hair and nail disorders are associated with HIV disease?

1. Cedeno-Laurent F, Gómez-Flores M, Mendez N, Ancer-Rodríguez J, Bryant JL, Gaspari AA, et al. New insights into HIV-1-primary skin disorders. J Int AIDS Soc. 2011 Jan 24. 14:5. [Medline]. [Full Text].

2. Altman K, Vanness E, Westergaard RP. Cutaneous manifestations of human immunodeficiency virus: a clinical update. Curr Infect Dis Rep. 2015 Mar. 17(3):464. [Medline].

3. Britto GR, Augustine M. Mucocutaneous manifestations of human immunodeficiency virus (HIV) infection in children in relation to the degree of immunosuppression. Int J Dermatol. 2019 Mar 29. [Medline].

4. Hwang A, Iskandar AS, Kerr WT, Farrell S, Plaxe SC, Dasanu CA. Clinico-epidemiologic characteristics and patterns of care in Kaposi's sarcoma: Data from a single-institution series. J Oncol Pharm Pract. 2019 Apr 2. 1078155219838614. [Medline].

5. Smith KJ, Skelton HG, Yeager J, Ledsky R, McCarthy W, Baxter D, et al. Cutaneous findings in HIV-1-positive patients: a 42-month prospective study. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR). J Am Acad Dermatol. 1994 Nov. 31(5 Pt 1):746-54. [Medline].

6. Zampogna JC, Flowers FP. Persistent verrucous varicella as the initial manifestation of HIV infection. J Am Acad Dermatol. 2001 Feb. 44(2 Suppl):391-4. [Medline].

7. Janniger CK, Gascon P, Schwartz RA, Hennessey NP, Lambert WC. Erythroderma as the initial presentation of the acquired immunodeficiency syndrome. Dermatologica. 1991. 183(2):143-5. [Medline].

8. Wiederkehr M, Schwartz RA. Giant proliferative molluscum contagiosum. Acta Derm Venerol (Ljubjlana). 2002;11:101-104.

9. Pignataro P, Rocha Ada S, Nery JA, Miranda A, Sales AM, Ferrreira H, et al. Leprosy and AIDS: two cases of increasing inflammatory reactions at the start of highly active antiretroviral therapy. Eur J Clin Microbiol Infect Dis. 2004 May. 23(5):408-11. [Medline].

10. Tzung TY, Yang CY, Chao SC, Lee JY. Cutaneous manifestations of human immunodeficiency virus infection in Taiwan. Kaohsiung J Med Sci. 2004 May. 20(5):216-24. [Medline].

11. Itin PH, Gilli L. Molluscum contagiosum mimicking sebaceous nevus of Jadassohn, ecthyma and giant condylomata acuminata in HIV-infected patients. Dermatology. 1994. 189(4):396-8. [Medline].

12. Puig L, Pradinaud R. Leishmania and HIV co-infection: dermatological manifestations. Ann Trop Med Parasitol. 2003 Oct. 97 Suppl 1:107-14. [Medline].

13. High WA, Evans CC, Hoang MP. Cutaneous miliary tuberculosis in two patients with HIV infection. J Am Acad Dermatol. 2004 May. 50(5 Suppl):S110-3. [Medline].

14. Diatta BA, Diallo M, Diadie S, Faye B, Ndiaye M, Hakim H, et al. [Cutaneous leishmaniasis due to Leishmania infantum associated with HIV]. Ann Dermatol Venereol. 2016 May 3. [Medline].

15. Chiewchanvit S, Tovanabutra N, Jariyapan N, Bates MD, Mahanupab P, Chuamanochan M, et al. Chronic generalized fibrotic skin lesions from disseminated leishmaniasis caused by Leishmania martiniquensis in two HIV-infected patients from northern Thailand. Br J Dermatol. 2015 Mar 30. [Medline].

16. Sinha S, Fernández G, Kapila R, Lambert WC, Schwartz RA. Diffuse cutaneous leishmaniasis associated with the immune reconstitution inflammatory syndrome. Int J Dermatol. 2008 Dec. 47(12):1263-70. [Medline].

17. Borkovic SP, Schwartz RA. Kaposi's sarcoma presenting in the homosexual man -- a new and striking phenomenon!. Ariz Med. 1981 Dec. 38(12):902-4. [Medline].

18. Goorney BP, Newsham J, Fitzgerald D, Motta L. Acroangiodermatitis mimicking Kaposi's sarcoma in an HIV-positive man. Int J STD AIDS. 2018 Jan 1. 956462417750709. [Medline].

19. Crum-Cianflone N, Hullsiek KH, Satter E, Marconi V, Weintrob A, Ganesan A, et al. Cutaneous malignancies among HIV-infected persons. Arch Intern Med. 2009 Jun 22. 169(12):1130-8. [Medline]. [Full Text].

20. Cox CM, El-Mallawany NK, Kabue M, Kovarik C, et al. Clinical Characteristics and Outcomes of HIV-Infected Children Diagnosed With Kaposi Sarcoma in Malawi and Botswana. Pediatr Blood Cancer. 2013 Mar 11. [Medline].

21. Wang J, Liang R, Hao C, Liu X, Zhang N, Duan X, et al. Survival outcomes of primary cutaneous T-cell lymphoma in HIV-infected patients: a national population-based study. J Investig Med. 2018 Jan 12. [Medline].

22. Tsao H, Tahan SR, Johnson RA. Chronic varicella zoster infection mimicking a basal cell carcinoma in an AIDS patient. J Am Acad Dermatol. 1997 May. 36(5 Pt 2):831-3. [Medline].

23. Leibovitz E, Cooper D, Giurgiutiu D, Coman G, Straus I, Orlow SJ, et al. Varicella-zoster virus infection in Romanian children infected with the human immunodeficiency virus. Pediatrics. 1993 Dec. 92(6):838-42. [Medline].

24. Leibovitz E, Kaul A, Rigaud M, Bebenroth D, Krasinski K, Borkowsky W. Chronic varicella zoster in a child infected with human immunodeficiency virus: case report and review of the literature. Cutis. 1992 Jan. 49(1):27-31. [Medline].

25. Davis MD, Gostout BS, McGovern RM, Persing DH, Schut RL, Pittelkow MR. Large plantar wart caused by human papillomavirus-66 and resolution by topical cidofovir therapy. J Am Acad Dermatol. 2000 Aug. 43(2 Pt 2):340-3. [Medline].

26. Kolokotronis A, Antoniades D, Katsoulidis E, Kioses V. Facial and perioral molluscum contagiosum as a manifestation of HIV infection. Aust Dent J. 2000 Mar. 45(1):49-52. [Medline].

27. Bournerias I, De Chauvin MF, Datry A, Chambrette I, Carriere J, Devidas A, et al. Unusual Microsporum canis infections in adult HIV patients. J Am Acad Dermatol. 1996 Nov. 35(5 Pt 2):808-10. [Medline].

28. Dharmshale SN, Patil SA, Gohil A, Chowdhary A, Oberoi C. Disseminated crytococcosis with extensive cutaneous involvement in AIDS. Indian J Med Microbiol. 2006 Jul. 24(3):228-30. [Medline].

29. K Ramdial P, Mosam A, Dlova NC, B Satar N, Aboobaker J, Singh SM. Disseminated cutaneous histoplasmosis in patients infected with human immunodeficiency virus. J Cutan Pathol. 2002 Apr. 29(4):215-25. [Medline].

30. Chande C, Menon S, Gohil A, Lilani S, Bade J, Mohammad S, et al. Cutaneous histoplasmosis in AIDS. Indian J Med Microbiol. 2010 Oct-Dec. 28(4):404-6. [Medline].

31. Chetchotisakd P, Anunnatsiri S, Nithichanon A, Lertmemongkolchai G. Cryptococcosis in anti-interferon-gamma autoantibodies-positive patients: a different clinical manifestation from HIV-infected patients. Jpn J Infect Dis. 2016 May 9. [Medline].

32. Plettenberg A, Lorenzen T, Burtsche BT, Rasokat H, Kaliebe T, Albrecht H, et al. Bacillary angiomatosis in HIV-infected patients--an epidemiological and clinical study. Dermatology. 2000. 201(4):326-31. [Medline].

33. DallaPiazza M, Akiyama MJ. The First Report of Bartonella quintana Immune Reconstitution Inflammatory Syndrome Complicated by Jarisch-Herxheimer Reaction. J Int Assoc Provid AIDS Care. 2017 Jan 1. 2325957417702484. [Medline].

34. Kayal JD, McCall CO. Sporotrichoid cutaneous Mycobacterium avium complex infection. J Am Acad Dermatol. 2002 Nov. 47(5 Suppl):S249-50. [Medline].

35. Rovery C, Rolain JM, Lepidi H, Zandotti C, Moreau J, Brouqui P. Bartonella quintana coinfection with Mycobacterium avium complex and CMV in an AIDS patient: case presentation. BMC Infect Dis. 2006 May 29. 6:89. [Medline]. [Full Text].

36. Courjon J, Hubiche T, Dupin N, Grange PA, Del Giudice P. Clinical Aspects of Syphilis Reinfection in HIV-Infected Patients. Dermatology. 2015 Mar 24. [Medline].

37. Balagula Y, Mattei PL, Wisco OJ, Erdag G, Chien AL. The great imitator revisited: the spectrum of atypical cutaneous manifestations of secondary syphilis. Int J Dermatol. 2014 Dec. 53(12):1434-41. [Medline].

38. Rodgers S, Leslie KS. Skin infections in HIV-infected individuals in the era of HAART. Curr Opin Infect Dis. 2011 Apr. 24(2):124-9. [Medline].

39. Boumis E, Chinello P, Della Rocca C, Paglia MG, Proietti MF, Petrosillo N. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient. Int J STD AIDS. 2006 May. 17(5):351-3. [Medline].

40. Mathes LE, Hayes KA, Kociba G. Evidence that high-dosage zidovudine at time of retrovirus exposure reduces antiviral efficacy. Antimicrob Agents Chemother. 1996 Sep. 40(9):2183-6. [Medline]. [Full Text].

41. Kaplan MH, Sadick NS, McNutt NS, Talmor M, Coronesi M, Hall WW. Acquired ichthyosis in concomitant HIV-1 and HTLV-II infection: a new association with intravenous drug abuse. J Am Acad Dermatol. 1993 Nov. 29(5 Pt 1):701-8. [Medline].

42. Boonchai W, Laohasrisakul R, Manonukul J, Kulthanan K. Pruritic papular eruption in HIV seropositive patients: a cutaneous marker for immunosuppression. Int J Dermatol. 1999 May. 38(5):348-50. [Medline].

43. Barcaui CB, Gonçalves da Silva AM, Sotto MN, Genser B. Stem cell apoptosis in HIV-1 alopecia. J Cutan Pathol. 2006 Oct. 33(10):667-71. [Medline].

44. Harry TC, Matthews M, Salvary I. Indinavir use: associated reversible hair loss and mood disturbance. Int J STD AIDS. 2000 Jul. 11(7):474-6. [Medline].

45. Saka B, Barro-Traore F, Atadokpede FA, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa: a multicentric study in four countries. Int J Dermatol. 2013 Jan 20. [Medline].

46. Yang C, Mosam A, Mankahla A, Dlova N, Saavedra A. HIV infection predisposes skin to toxic epidermal necrolysis via depletion of skin-directed CD4⁺ T cells. J Am Acad Dermatol. 2014 Mar 12. [Medline].

47. Vin-Christian K, Epstein JH, Maurer TA, McCalmont TH, Berger TG. Photosensitivity in HIV-infected individuals. J Dermatol. 2000 Jun. 27(6):361-9. [Medline].

48. Ingen-Housz-Oro S, Sbidian E, Ortonne N, et al. HIV-Related CD8+ Cutaneous Pseudolymphoma: Efficacy of Methotrexate. Dermatology. 2013 Jan 22. [Medline].

49. Martinelli C, Azzi A, Buffini G, Comin CE, Leoncini F. Cutaneous vasculitis due to human parvovirus B19 in an HIV-infected patient: report of a case. AIDS. 1997 Dec. 11(15):1891-3. [Medline].

50. Rachline A, Lariven S, Descamps V, Grossin M, Bouvet E. Leucocytoclastic vasculitis and indinavir. Br J Dermatol. 2000 Nov. 143(5):1112-3. [Medline].

51. Ellaurie M, Rubinstein A, Rosenstreich DL. IgE levels in pediatric HIV-1 infection. Ann Allergy Asthma Immunol. 1995 Oct. 75(4):332-6. [Medline].

52. Yu RC, Evans B, Cream JJ. Cold urticaria, raised IgE and HIV infection. J R Soc Med. 1995 May. 88(5):294P-295P. [Medline]. [Full Text].

53. Handler NS, Handler MZ, Stephany MP, Handler GA, Schwartz RA. Porphyria cutanea tarda: an intriguing genetic disease and marker. Int J Dermatol. 2017 Mar 21. [Medline].

54. Molinero J, Vilata JJ, Nagore E, Obón L, Grau C, Aliaga A. Ashy dermatosis in an HIV antibody-positive patient. Acta Derm Venereol. 2000 Jan-Feb. 80(1):78-9. [Medline].

55. Kanitakis J, Carbonnel E, Delmonte S, Livrozet JM, Faure M, Claudy A. Multiple eruptive dermatofibromas in a patient with HIV infection: case report and literature review. J Cutan Pathol. 2000 Jan. 27(1):54-6. [Medline].

56. García-Patos V, Repiso T, Rodríguez-Cano L, Castells A. Ofuji papuloerythroderma in a patient with the acquired immunodeficiency syndrome. Dermatology. 1996. 192(2):164-6. [Medline].

57. Duvic M, Reisman M, Finley V, Rapini R, DiLuzio NR, Mansell PW. Glucan-induced keratoderma in acquired immunodeficiency syndrome. Arch Dermatol. 1987 Jun. 123(6):751-6. [Medline].

58. Kanitakis J, Misery L, Nicolas JF, Lyonnet S, Chouvet B, Haftek M, et al. Disseminated superficial porokeratosis in a patient with AIDS. Br J Dermatol. 1994 Aug. 131(2):284-9. [Medline].

59. Desnoyer A, Dupin N, Assoumou L, Carlotti A, Gaudin F, Deback C, et al. Expression pattern of the CXCL12/CXCR4-CXCR7 trio in Kaposi's sarcoma skin lesions. Br J Dermatol. 2016 May 13. [Medline].

60. Meadows KP, Tyring SK, Pavia AT, Rallis TM. Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir. Arch Dermatol. 1997 Aug. 133(8):987-90. [Medline].

61. Berman B, Flores F, Burke G 3rd. Efficacy of pentoxifylline in the treatment of pruritic papular eruption of HIV-infected persons. J Am Acad Dermatol. 1998 Jun. 38(6 Pt 1):955-9. [Medline].

62. Misago N, Narisawa Y, Matsubara S, Hayashi S. HIV-associated eosinophilic pustular folliculitis: successful treatment of a Japanese patient with UVB phototherapy. J Dermatol. 1998 Mar. 25(3):178-84. [Medline].

Robert A Schwartz, MD, MPH Professor and Head of Dermatology, Professor of Pathology, Pediatrics, Medicine, and Preventive Medicine and Community Health, Rutgers New Jersey Medical School; Visiting Professor, Rutgers University School of Public Affairs and Administration

Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, New York Academy of Medicine, American Academy of Dermatology, American College of Physicians, Sigma Xi

Disclosure: Nothing to disclose.

Emel Erdal, MD Associate Professor of Dermatology, Mesa Hospital, Turkey

Disclosure: Nothing to disclose.

Anna Zalewska, MD, PhD Professor of Dermatology and Venereology, Psychodermatology Department, Chair of Clinical Immunology and Microbiology, Medical University of Lodz, Poland

Disclosure: Nothing to disclose.

David F Butler, MD Former Section Chief of Dermatology, Central Texas Veterans Healthcare System; Professor of Dermatology, Texas A&M University College of Medicine; Founding Chair, Department of Dermatology, Scott and White Clinic

David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Society for MOHS Surgery, Association of Military Dermatologists, Phi Beta Kappa

Disclosure: Nothing to disclose.

Julia R Nunley, MD Professor, Program Director, Dermatology Residency, Department of Dermatology, Virginia Commonwealth University Medical Center

Julia R Nunley, MD is a member of the following medical societies: American Academy of Dermatology, American College of Physicians, American Society of Nephrology, International Society of Nephrology, Medical Dermatology Society, Medical Society of Virginia, National Kidney Foundation, Phi Beta Kappa, Women's Dermatologic Society

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: American Board of Dermatology<br/>Co-Editor for the text Dermatological Manifestations of Kidney Disease .

William D James, MD Paul R Gross Professor of Dermatology, Vice-Chairman, Residency Program Director, Department of Dermatology, University of Pennsylvania School of Medicine

William D James, MD is a member of the following medical societies: American Academy of Dermatology, Society for Investigative Dermatology

Disclosure: Received income in an amount equal to or greater than $250 from: Elsevier; WebMD.

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous author Randa M Hamadeh, MD, to the development and writing of the source article.